HomeAI · summaries
Storia in 19 fonti
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a tumultuous approval process. The vaccine (mFlusiva, Moderna) is approved for adults aged 50 years or older. It is the fifth mRNA vaccine approved for use in the United States, which include Moderna’s two COVID-19 shots and
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a…
- ·
biopharmadive.com
FDA approves Moderna’s mRNA flu vaccine
The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.
